Science and Health News

The Human Vaccines Project welcomes Crucell Holland B.V., one of the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen), as the newest industry partner in its effort to accelerate the research and development of vaccines and immunotherapies for infectious diseases and cancer.

New research from Institute for Medical Research Israel-Canada (IMRIC) in Hebrew University's Faculty of Medicine

Delivering the hormone leptin directly to the brain through gene therapy aids weight loss without the significant side effect of bone loss, according to new collaborative research from Oregon State University and University of Florida.

Researchers observe one of the world's fastest chemical reactions for the first time UV radiation often damages our DNA. Researchers at Kiel University and The University of Bristol, Great Britain, have now seen for the first time what happens in DNA building blocks when they are stimulated by ultraviolet light, and what they do to prevent themselves from being destroyed. The results show: the molecules use the absorbed energy to set off a completely harmless reaction which prevents the genes being altered. The study can be found in the current edition of the journal Angewandte Chemie (Applied Chemistry).

The hunt for a vaccine against malaria in pregnant women has provided an unexpected side benefit for Danish researchers, namely what appears to be an effective weapon against cancer. The scientists behind the vaccine aim for tests on humans within four years.

Researchers found that variation in brain connectivity and an individual’s traits lay on a single axis — where those with classically positive lifestyles and behaviours had different connections to those with classically negative ones.

Researchers at Medical Biological Union (MBU), a biotech company in Novosibirsk, in Siberia, have come up with a new immune-enzyme test system that is said to be able to identify four of the world’s most dangerous viruses simultaneously, the Russian news agency TASS reported, citing Darya Popova, the developer’s head of marketing.

Published in Nature Communications, the findings show how a nanoscale, synthetic 'diamond' can light up early-stage cancers in MRI scans.